Sino-America clinical-stage biotech Eccogene announced that it will receive a $60 million payment from AstraZeneca, which is ...

Monopar Therapeutics' market value nearly tripled Thursday after the biotechnology company agreed to license a treatment for patients with a rare genetic condition from AstraZeneca unit Alexion.

AstraZeneca has rolled out a fresh TV spot for its blockbuster-to-be Breztri, hitting the me | AstraZeneca has rolled out a ...

AstraZeneca, a global biopharmaceutical company that develops and commercializes prescription medicines, became a household ...

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune ...

The CHMP recommends approval for AZN's Wainzua for treating polyneuropathy associated with hereditary transthyretin-mediated ...

Monopar Therapeutics shares rose after the biotechnology company agreed to license a treatment for patients with a rare genetic condition from AstraZeneca unit Alexion. Shares of the Wilmette, Ill., ...

Capital Investment Advisors LLC cut its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 8.3% during the ...

As we continue to put a spotlight on Breast Cancer Awareness month, we're talking about the importance of health equity.

Hechler-Fayd’herbe believes that the Bank of England’s interest rate cuts would potentially lead to a rally in UK equities.

Claro Advisors LLC bought a new position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) during the third quarter, ...

Eccogene will receive a $60 million payment from AstraZeneca (AZN), which is being triggered by successfully achieving milestones related to the development of ECC5004/AZD5004 including the first ...